Evidence map›Paper›PMID 27625337›Full record

ArticleCirculation. Cardiovascular genetics2016

Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.

Robert Hastings, Carin P de Villiers, Charlotte Hooper, Liz Ormondroyd, Alistair Pagnamenta, Stefano Lise, Silvia Salatino, Samantha J L Knight, Jenny C Taylor, Kate L Thomson and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Circulation. Cardiovascular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. A Case Study Identified a New Mutation in theInternational journal of general medicine · 2025
    Article
  6. Dilated Cardiomyopathy: A Genetic Journey from Past to Future.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Review
  9. Case reports in genetics · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Discerning the Ambiguous Role of MissenseJournal of personalized medicine · 2022
    Article
  17. Understanding the molecular basis of cardiomyopathy.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Robert Hastings
Carin P de Villiers
Charlotte Hooper
Liz Ormondroyd
Alistair Pagnamenta
Stefano Lise
Silvia Salatino
Samantha J L Knight
Jenny C Taylor
Kate L Thomson
Linda Arnold
Spyros D Chatziefthimiou
Petr V Konarev
Matthias Wilmanns
Elisabeth Ehler
Andrea Ghisleni
Mathias Gautel
Edward Blair
Hugh Watkins
Katja Gehmlich
Arnold Ventures · USEdward Hospital · USElisa (Finland) · FIFamily Works · USOrmond (United States) · US

Funding

British Heart Foundation CH/08/001/25300British Heart Foundation FS/12/40/29712British Heart Foundation PG/15/113/31944British Heart Foundation RE/13/1/30181British Heart Foundation RG/12/16/29939British Heart Foundation RG/15/8/31480Department of Health NIHR-HCS-D13-04-006Medical Research Council MR/J010456/1Medical Research Council MR/K015664/1Wellcome Trust 090532Wellcome Trust 201543/Z/16/Z
6 · The paper itself

Abstract

backgroundHigh throughput next-generation sequencing techniques have made whole genome sequencing accessible in clinical practice; however, the abundance of variation in the human genomes makes the identification of a disease-causing mutation on a background of benign rare variants challenging. METHODS AND

resultsHere we combine whole genome sequencing with linkage analysis in a 3-generation family affected by cardiomyopathy with features of autosomal dominant left ventricular noncompaction cardiomyopathy. A missense mutation in the giant protein titin is the only plausible disease-causing variant that segregates with disease among the 7 surviving affected individuals, with interrogation of the entire genome excluding other potential causes. This A178D missense mutation, affecting a conserved residue in the second immunoglobulin-like domain of titin, was introduced in a bacterially expressed recombinant protein fragment and biophysically characterized in comparison to its wild-type counterpart. Multiple experiments, including size exclusion chromatography, small-angle x ray scattering, and circular dichroism spectroscopy suggest partial unfolding and domain destabilization in the presence of the mutation. Moreover, binding experiments in mammalian cells show that the mutation markedly impairs binding to the titin ligand telethonin.

conclusionsHere we present genetic and functional evidence implicating the novel A178D missense mutation in titin as the cause of a highly penetrant familial cardiomyopathy with features of left ventricular noncompaction. This expands the spectrum of titin's roles in cardiomyopathies. It furthermore highlights that rare titin missense variants, currently often ignored or left uninterpreted, should be considered to be relevant for cardiomyopathies and can be identified by the approach presented here.

Indexed as

Genetic LinkageHigh-Throughput Nucleotide SequencingMutation, MissenseAdultAgedAged, 80 and overAnimalsChlorocebus aethiopsComputational BiologyConnectinCOS CellsDatabases, GeneticDNA Mutational AnalysisEchocardiographyFemaleGenetic MarkersConnectinGenetic MarkersTCAP protein, humanTTN protein, humancardiomyopathyleft ventricular noncompactionmissense mutationtelethonintitinwhole genome sequencing

Identifiers

PMID27625337
PMCPMC5068189
OpenAlexW2519784141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.